Tandem Diabetes Care target price cut to $25 from $27
TNDM•Wells Fargo cut its target price for Tandem Diabetes Care to $25 from $27.
Related News
TELUS swings to Q3 2026 net loss of C$660 million
TU•
iRhythm Holdings price objective cut to $150 from $180 by BofA Global Research
IRTC•
Appian Corp: Morgan Stanley raises target price to $57 from $32
APPN•
Centuri Holdings: Wells Fargo cuts target price to $24 from $28
CTRI•
Atmus Q3 sales beat expectations on Koch Filter acquisition; lifts outlook
ATMU•